Cannabis and cannabinoids in the United States

Global business and regulatory news covering the cannabis industry

31st December 2024

How did we do? CannIntelligence’s predictions for 2024 under review

20th December 2024

Recreational cannabis plans dashed, medical and IHDCs on the up in 2024

12th December 2024

On the latest Trump picks for attorney general and to head FDA and agriculture

More News analysis

Daily regulatory updates of legal changes in the cannabis sector, including monthly compilations

18th December 2024: US - Federal: Congressional House leaders have introduced a continuing resolution to fund the government that includes a one-year extension of the 2018 Farm Bill, press reports. The resolution would fund the government until 14th March but would leave the current Farm Bill in place for at least another year. The status quo would be a boon for the cannabinoid hemp industry, as both parties have previously introduced drafts of a new Farm Bill that would have changed the definition of hemp to reduce the amount of THC that may be contained in hemp. A new Farm Bill is normally passed about every five years, but this would be the second one-year extension after the five-year period.
17th December 2024: US - Ohio: Ohio lawmakers are unlikely to pass a bill restricting delta-8 and synthetic hemp products before the legislative session ends, according to Senate president Matt Huffman. He said the House isn’t interested in the proposal, leaving little time to reach an agreement. Huffman believes the bill is unlikely to move forward, as he said the House showed little interest in a similar effort last December to address issues with the “marijuana initiative”, media reports.
13th December 2024: US - Nebraska: Governor Jim Pillen has signed proclamations that certified the enactment of measure 437 and measure 438. In November, more than 70% of voters across the state approved legalising and regulating medical cannabis. Both measures are now law in the state of Nebraska.
11th December 2024: US - Florida: The Florida Department of Health’s Office of Medical Marijuana Use has published a list of 22 companies that received “letters of intent to approve” their application. In April 2023, 74 applicants initially applied for Medical Marijuana Treatment Center permits. Florida is expanding its medical marijuana market, weeks after the recent failure of Amendment 3 – which aimed to legalise recreational cannabis but fell short of the required 60% approval.
3rd December 2024: US - Federal: The US Drug Enforcement Administration (DEA) has begun hearings to address the Biden administration’s proposal to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). According to a DEA advisory released on 26th November, the primary goal was to organise the procedural groundwork for addressing the merits of rescheduling. A key part of yesterday’s hearing was about determining witnesses’ availability for subsequent hearings featuring witness testimony. DEA administrative law judge John Mulrooney said witness testimonies are likely to begin in mid-January.
22nd November 2024: US - Kentucky: Governor Andy Beshear has announced that, starting 1st December, qualified patients in Kentucky will be able to receive a doctor’s recommendation to access medical cannabis. He said: “Beginning 1st December, the authorised practitioners will be able to begin issuing valid written certifications to Kentucky patients.” The governor’s administration has created a web portal called the Kentucky Medical Cannabis Practitioner Directory to help connect patients with medical providers as it prepares for the start of its medical cannabis programme in 2025.
19th November 2024: US - Federal: Senate Democrats on the Committee on Agriculture, Nutrition, and Forestry have released a draft of the Farm Bill that would introduce changes to federal hemp laws and eliminate most intoxicating hemp-derived cannabinoid (IHDC) products. The bill proposes a change to how hemp is defined. Currently, hemp is federally legal if it contains no more than 0.3% delta-9 THC by dry weight. The new bill would revise this by requiring hemp to be tested for “total THC” content, which includes cannabinoids like delta-8 THC and tetrahydrocannabinolic acid (THCA), rather than only delta-9 THC. The draft bill introduces a definition for “industrial hemp”, which includes fibre, stalks, grain, oil, seeds and other components of the plant that “will not be used in the manufacturing or synthesis of natural or synthetic cannabinoid products”.
14th November 2024: US - Texas: A number of bills have been introduced that would expand the medical cannabis programme in Texas. Senate Bill (SB) 170 proposes replacing the term “low-THC cannabis” with “medical cannabis” in state law. It would also introduce new regulations on product testing, packaging, labelling, statewide retail locations, caregivers and other aspects of the expanded programme. SB 259 would also expand the state’s medical cannabis programme by allowing medical professionals and scientific research to determine the conditions and symptoms eligible for prescriptions. House Bill (HB) 1146 would expand the list of qualifying conditions, enabling patients to access Texas’s low-THC medical marijuana to treat “a condition that causes chronic pain, for which a physician would otherwise prescribe an opioid”. House Joint Resolution (HJR) 70 proposes a constitutional amendment that would direct the legislature to “authorise and regulate the possession, cultivation, and sale of cannabis for medical use in this state”.
14th November 2024: US - Texas: House Bill (HB) 1113, which would control the production and regulation of hemp in Texas, has been introduced. The bill would further establish a permit that would be required of hemp researchers and would create a criminal offence for cultivating hemp without a licence.
14th November 2024: US - Texas: A number of bills have been introduced relating to recreational cannabis. House Bill (HB) 1208 would legalise recreational cannabis and establish a regulated market for its production and sale in the state. If passed, the bill would allow licensed businesses, or “cannabis establishments”, to grow, process, test and sell cannabis products within Texas, while adults (21+) would be permitted to possess and use cannabis legally, with the limit set at 2.5 oz of dried flower and 15 g of concentrates. HB 848 would expand the state’s criminal code around cannabis possession and delivery to include “marihuana concentrate”.
11th November 2024: US - Ohio: Senate Bill (SB) 326, which would ban the sale of intoxicating hemp products in Ohio, has been introduced. SB 326 would define intoxicating hemp products as containing more than 0.5 mg of delta-9 THC per serving, 2 mg of delta-9 THC per package, or 0.5 mg of total non-delta-9 THC per package. The bill states that this act is an emergency measure “to protect Ohioans, especially Ohio’s youth, from untested, unregulated dangerous tetrahydrocannabinol (THC) products”, and would therefore go into immediate effect.
6th November 2024: US - South Dakota: South Dakota voters rejected measure 29, which would have legalised recreational cannabis in the state, with 57% casting ballots in opposition. The 2024 election marks South Dakota’s third attempt to legalise adult-use cannabis. With measure 29’s failure, the state will remain a medical cannabis-only state.

Full-length in-depth reports with detailed data and analysis for individual markets around the world

25th July 2024

Developments and trends in the global cannabis industry, Q2 2024

19th July 2024

Intoxicating hemp-derived cannabinoids: the US market, July 2024

16th May 2023

Intoxicating hemp-derived cannabinoids: the European online market

More Market reports

Regulatory reports

Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies

25th July 2024

Developments and trends in the global cannabis industry, Q2 2024

29th January 2024

An analysis of intoxicating cannabinoid beverages in the US

24th November 2023

A comparative analysis of medical cannabis programmes across the globe

More Regulatory reports

Up-to-date information and insights on brands, pricing and retail across selected markets

22nd September 2023

US CBD insights dashboard, 2023

6th April 2023

US: online retailer status, Q1 2023

17th March 2023

CBD and IHDC online retailer database

More Market data

Regulatory databases

Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables

30th December 2024

US regulatory tracker: medical and recreational cannabis

3rd December 2024

Regulatory tracker: current global regulation of recreational cannabis

3rd December 2024

Regulatory tracker: current global regulation of medical cannabis

More Regulatory databases

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Corporate Email*

Name*

Name

This field is for validation purposes and should be left unchanged.